Reece A, Hulse G
Front Psychiatry. 2023; 14:1182535.
PMID: 37732074
PMC: 10507876.
DOI: 10.3389/fpsyt.2023.1182535.
Reece A, Hulse G
Int J Environ Res Public Health. 2023; 20(4).
PMID: 36834053
PMC: 9967951.
DOI: 10.3390/ijerph20043360.
Reece A, Hulse G
J Xenobiot. 2023; 13(1):42-74.
PMID: 36810431
PMC: 9944119.
DOI: 10.3390/jox13010006.
Reece A, Hulse G
Pediatr Rep. 2023; 15(1):69-118.
PMID: 36810339
PMC: 9944887.
DOI: 10.3390/pediatric15010009.
Reece A, Hulse G
Genes (Basel). 2023; 14(1).
PMID: 36672773
PMC: 9858221.
DOI: 10.3390/genes14010032.
European Epidemiological Patterns of Cannabis- and Substance-Related Congenital Neurological Anomalies: Geospatiotemporal and Causal Inferential Study.
Reece A, Hulse G
Int J Environ Res Public Health. 2023; 20(1).
PMID: 36612763
PMC: 9819725.
DOI: 10.3390/ijerph20010441.
Off-target pharmacological profiling of synthetic cannabinoid receptor agonists including AMB-FUBINACA, CUMYL-PINACA, PB-22, and XLR-11.
Kevin R, Cairns E, Boyd R, Arnold J, Bowen M, McGregor I
Front Psychiatry. 2023; 13:1048836.
PMID: 36590635
PMC: 9798004.
DOI: 10.3389/fpsyt.2022.1048836.
Epidemiological Patterns of Cannabis- and Substance- Related Congenital Uronephrological Anomalies in Europe: Geospatiotemporal and Causal Inferential Study.
Reece A, Hulse G
Int J Environ Res Public Health. 2022; 19(21).
PMID: 36360648
PMC: 9657099.
DOI: 10.3390/ijerph192113769.
Cannabis- and Substance-Related Epidemiological Patterns of Chromosomal Congenital Anomalies in Europe: Geospatiotemporal and Causal Inferential Study.
Reece A, Hulse G
Int J Environ Res Public Health. 2022; 19(18).
PMID: 36141481
PMC: 9517644.
DOI: 10.3390/ijerph191811208.
Effects of cannabis on congenital limb anomalies in 14 European nations: A geospatiotemporal and causal inferential study.
Reece A, Hulse G
Environ Epigenet. 2022; 8(1):dvac016.
PMID: 35966826
PMC: 9364687.
DOI: 10.1093/eep/dvac016.
European epidemiological patterns of cannabis- and substance-related congenital cardiovascular anomalies: geospatiotemporal and causal inferential study.
Reece A, Hulse G
Environ Epigenet. 2022; 8(1):dvac015.
PMID: 35966825
PMC: 9364688.
DOI: 10.1093/eep/dvac015.
European Epidemiological Patterns of Cannabis- and Substance-Related Body Wall Congenital Anomalies: Geospatiotemporal and Causal Inferential Study.
Reece A, Hulse G
Int J Environ Res Public Health. 2022; 19(15).
PMID: 35897396
PMC: 9330494.
DOI: 10.3390/ijerph19159027.
Geotemporospatial and causal inferential epidemiological overview and survey of USA cannabis, cannabidiol and cannabinoid genotoxicity expressed in cancer incidence 2003-2017: part 3 - spatiotemporal, multivariable and causal inferential pathfinding....
Reece A, Hulse G
Arch Public Health. 2022; 80(1):101.
PMID: 35354499
PMC: 8969240.
DOI: 10.1186/s13690-022-00813-6.
Geotemporospatial and causal inferential epidemiological overview and survey of USA cannabis, cannabidiol and cannabinoid genotoxicity expressed in cancer incidence 2003-2017: part 2 - categorical bivariate analysis and attributable fractions.
Reece A, Hulse G
Arch Public Health. 2022; 80(1):100.
PMID: 35354495
PMC: 8969377.
DOI: 10.1186/s13690-022-00812-7.
Geotemporospatial and causal inferential epidemiological overview and survey of USA cannabis, cannabidiol and cannabinoid genotoxicity expressed in cancer incidence 2003-2017: part 1 - continuous bivariate analysis.
Reece A, Hulse G
Arch Public Health. 2022; 80(1):99.
PMID: 35354487
PMC: 8966217.
DOI: 10.1186/s13690-022-00811-8.
Geotemporospatial and causal inference epidemiological analysis of US survey and overview of cannabis, cannabidiol and cannabinoid genotoxicity in relation to congenital anomalies 2001-2015.
Reece A, Hulse G
BMC Pediatr. 2022; 22(1):47.
PMID: 35042455
PMC: 8767720.
DOI: 10.1186/s12887-021-02996-3.
Epidemiological overview of multidimensional chromosomal and genome toxicity of cannabis exposure in congenital anomalies and cancer development.
Reece A, Hulse G
Sci Rep. 2021; 11(1):13892.
PMID: 34230557
PMC: 8260794.
DOI: 10.1038/s41598-021-93411-5.
Evaluation of Cytotoxic and Mutagenic Effects of the Synthetic Cathinones Mexedrone, α-PVP and α-PHP.
Lenzi M, Cocchi V, Gasperini S, Arfe R, Marti M, Hrelia P
Int J Mol Sci. 2021; 22(12).
PMID: 34204826
PMC: 8231654.
DOI: 10.3390/ijms22126320.
A geospatiotemporal and causal inference epidemiological exploration of substance and cannabinoid exposure as drivers of rising US pediatric cancer rates.
Reece A, Hulse G
BMC Cancer. 2021; 21(1):197.
PMID: 33632159
PMC: 7908679.
DOI: 10.1186/s12885-021-07924-3.
Can Hemp Help? Low-THC Cannabis and Non-THC Cannabinoids for the Treatment of Cancer.
Afrin F, Chi M, Eamens A, Duchatel R, Douglas A, Schneider J
Cancers (Basel). 2020; 12(4).
PMID: 32340151
PMC: 7226605.
DOI: 10.3390/cancers12041033.